Pharma reps transition from hard sell to support

01/9/2012 | Wall Street Journal, The

Some pharma sales representatives are shifting to a more supportive role in the face of industry consolidation, dry pipelines, FDA scrutiny and physician schedules, representatives say. "Increasing physician satisfaction, it turns out, is a much better way to promote a pharmaceutical agent than simply telling them to write more prescriptions or what the benefits [are]," said David Ricks, president of Eli Lilly & Co.'s global business unit. Nonetheless, many doctors refuse to see drug reps, often because they have no time or have had unpleasant experiences with reps, says Chris Wright of ZS Associates.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN